Latest filing published 04 Feb 2016 for OncBioMune Pharmaceuticals, Inc.
Insider track record
No signal scores available.
Robert Lange Elliot Jr.: trading record in brief
Robert Lange Elliot Jr. is a declared insider of OncBioMune Pharmaceuticals, Inc, with filings sourced from SEC (Form 4). We count 2 filings, every one of them for a trade on 2 September 2015.
Every open-market trade on record is a sale: 1 sale worth €924. Besides market trades, the filings include 1 share grant. So far in 2016, the count stands at no purchases and 1 sale.
Most recently, on 4 February 2016, the filings show a share grant in OncBioMune Pharmaceuticals, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Lange Elliot Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,951,079 sharesCommon stockSEC:0001493152-16-007166:0
- 1,025,000 shares@ US$0.001100.0% of flowCommon stockSEC:0001493152-16-007166:1
2 of 2 declarations